滋血養筋湯이 부신피질호르몬에 의해 억제된 조골세포 기능에 미치는 영향
Effects of JY on Osteoblastic Cell from Rat Calvariae in the Presence of Glucocorticoid
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The inhibition of osteoblast by glucocorticoid is recognized as its action mechanism of decreased bone formation. In this study, the effect of JY, Jahyulyangkeuntang, on the differentiation and mineralization of osteoblastic cells was investigated in the presence of dexamethasone. The cell counting, enzyme activity assay, MTT assay, collagen content assay were done to determine the cell proliferation, alkaline phosphatase(ALP) activity, bone martrix production, and cell apoptosis. JY enhanced the cell proliferation after the culture for 10 days. ALP activity and total protein synthesis, and intracellular collagen synthesis were increased when the cells were treated with JY. And JY restored calvarial cell function decreased by dexamethasone.
Abstract
The inhibition of osteoblast by glucocorticoid is recognized as its action mechanism of decreased bone formation. In this study, the effect of JY, Jahyulyangkeuntang, on the differentiation and mineralization of osteoblastic cells was investigated in the presence of dexamethasone. The cell counting, enzyme activity assay, MTT assay, collagen content assay were done to determine the cell proliferation, alkaline phosphatase(ALP) activity, bone martrix production, and cell apoptosis. JY enhanced the cell proliferation after the culture for 10 days. ALP activity and total protein synthesis, and intracellular collagen synthesis were increased when the cells were treated with JY. And JY restored calvarial cell function decreased by dexamethasone.
참고문헌 (13)
- Van Staa, T.P, "Use of oral corticosteroids and risk of fracture", Bone Miner, 15, pp.993~1000 (2000)
- Crandall C, "Parathyroid hormone for treatment of osteoporosis", Arch Intern Med, 162, pp.2297~2309 (2002)
- Manelli, F, "Glucocorticoidinduced osteoporosis. Trends Endocrinol", Metab, 11, pp.79~85 (2000)
- Dijke P, "The Signal transduction of bone morphogenetic proteins in osteoblast differentiation", Bone Joint Surg, 85, pp.34~38 (2003)
- Olney RC, "Regulation of bone mass by growth hormone", Pediatr Oncol, 41, pp.128~134 (2003)
- Xing L, "Regulation of apoptosis in osteoclasts and osteoblastic cells", Biochem Biophys Res Commun, 328, pp.70~2 (2005)
- Kim S, "Activation of receptor activator of NF-kappaB ligand gene expression by 1,25-dihydroxyvitamin D3 is mediated through multiple long-range enhancers", Mol Cell Biol, 26(17), pp.6469~6486 (2006)
- Hurley M, "Changes in serum fibroblast growth factor 2 in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34)", Osteoporos, 16(12), pp.2080~2084 (2005)
- 양미자, 박태선, 김연정, "십전대보탕 및 자혈양근탕 첨가식이가 흰쥐의 철분 생체이용률에 미치는 영향", 한국영양학회지, 36(3), pp.262~269 (2003), 한국영양학회
- 임현정, 박태선, 황귀서, "자혈양근탕 및 양혈장근건보환이 인체 소장 상피세포주 (Caco-2) 모델에서 칼슘 흡수에 미치는 영향", 한국영양학회지, 35(4), pp.446~453 (2002), 한국영양학회
- Weinstein RS, "Inhibition of osteoblastogenesisand promotion of apoptosis pf osteoblastsand osteocytes by glucocorticoids. Potentialmechanisms of their deleterious effectson bone", pp.274~282 (1998), Clin. Invest
- Weinstein RS, "Manolagas SC. Promotionof osteoclast survival and antagonism ofbisphosphonate-induced osteoclast apoptosisby glucocorticoids", Clin Invest, 109(8), pp.1041~1048 (2002)
- 윤용갑, "新東醫方劑2223도해임상활용", pp.1759~ (2006), 도서출판 정담